IP Library › Granted Patent US 12,186,101
Granted Patent B2
US 12,186,101 · App. 17/101,984 · Granted Jan 7, 2025

Insertable physiological monitor injector tool

Inventors: Gust H. Bardy (Carnation, WA); Jared Floyd (Ferndale, WA); John Choi (Seattle, WA); Daniel L. Reddy (Seattle, WA); Brian Cran (Seattle, WA)
Assignee: Bardy Diagnostics, Inc.
A61B5/6865A61B2560/0204A61B2560/063
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,101
App. No.
17/101,984
Granted
Jan 7, 2025
Kind
B2
Abstract

An insertable physiological monitor injector tool is provided. An elongated handle includes a recess formed along a longitudinal axis and has an opening on a distal end. An insertion tube has a hollow elongated shape that is movably positioned within the elongated handle, in the recess. A stationary arbor is affixed on a proximal end to a proximal end of the elongated handle and extends through the insertion tube when the insertion tube is in a retracted position. A tab is affixed to the insertion tube, wherein the tab can lock the insertion tube in an extended position.

Claims (37)

1. An insertable physiological monitor injector tool, comprising:

a cylindrical handle within which a recess is formed along a longitudinal axis and comprising an opening on a distal end, wherein a hollow structure is housed in the recess;

a stationary arbor affixed to a proximal end of the cylindrical handle, wherein the stationary arbor is configured to extend past the distal end of the cylindrical handle, and wherein the stationary arbor is configured to extend past a distal end of the hollow structure when the hollow structure is in a fully retracted position; and

an implantable cardiac monitor, wherein the implantable cardiac monitor is inductively chargeable while preloaded in the hollow structure of the insertable physiological monitor injector tool,

wherein the hollow structure of the insertable physiological monitor injector tool is comprised of plastic and configured to inject the implantable cardiac monitor preloaded in the hollow structure into a chest of a patient, and

wherein the hollow structure includes a beveled end, wherein the beveled end bends inwards into the hollow structure and is configured to secure the implantable cardiac monitor within the hollow structure prior to implantation but allow the hollow structure to retract over the implantable cardiac monitor during implantation, and at least a portion of the beveled end is inserted into the chest of the patient during implantation of the implantable cardiac monitor.

2. The insertable physiological monitor injector tool according to claim 1 , wherein the hollow structure comprises an insertion tube having a hollow elongated shape.

3. The insertable physiological monitor injector tool according to claim 2 , further comprising a tab affixed to the insertion tube, wherein the tab is configured to lock the insertion tube in an extended position.

4. An insertable physiological monitor injector tool, comprising:

a cylindrical handle within which a recess is formed along a longitudinal axis and comprising an opening on a distal end;

a hollow elongated tube that is movably positioned within the cylindrical handle, in the recess, and comprising a cutout formed in a surface on one end of the hollow elongated tube in a shape of a square or rectangle and a beveled end opposite the end with the cutout, wherein the beveled end bends inwards into the hollow elongated tube and is configured to secure an implantable physiological monitor within the hollow elongated tube prior to implantation but allow the hollow elongated tube to retract over the implantable physiological monitor during implantation,

wherein the implantable physiological monitor is inductively chargeable while preloaded in the hollow elongated tube;

a stationary arbor affixed to a proximal end of the cylindrical handle, wherein the stationary arbor is configured to extend past a distal end of the cylindrical handle, and wherein the stationary arbor is configured to extend past a distal end of the hollow elongated tube when the hollow elongated tube is in a fully retracted position; and

a tab affixed directly to the hollow elongated tube via the cutout formed in the surface of the hollow elongated tube, wherein a bottom of the tab is secured into the cutout and a top of the tab extends outside the cylindrical handle, and the tab is configured to lock the hollow elongated tube in an extended position.

5. The insertable physiological monitor injector tool according to claim 4 , wherein the hollow elongated tube is configured to accept the implantable physiological monitor when the hollow elongated tube is in the extended position.

6. The insertable physiological monitor injector tool according to claim 4 , wherein a channel is formed within a portion of the cylindrical handle, on the proximal end, to allow movement of the tab.

7. The insertable physiological monitor injector tool according to claim 6 , wherein the hollow elongated tube is configured to retract into the cylindrical handle via the recess upon movement of the tab in the channel towards a proximal end of the cylindrical handle.

8. The insertable physiological monitor injector tool according to claim 4 , wherein the hollow elongated tube is made from plastic.

9. The insertable physiological monitor injector tool according to claim 4 , wherein a distal end of the hollow elongated tube is sharpened.

10. The insertable physiological monitor injector tool according to claim 4 , further comprising:

one or more sets of guides formed on an interior surface of the recess and shaped to surround at least a portion of the hollow elongated tube in the recess.

11. The insertable physiological monitor injector tool according to claim 4 , further comprising:

a tip formed on a distal end of the hollow elongated tube.

12. An insertable physiological monitor injector tool system, comprising:

a cylindrical handle within which a recess is formed along a longitudinal axis;

a hollow elongated tube that is movably positioned within the cylindrical handle, in the recess, and comprising a cutout formed in a surface on one end of the hollow elongated tube in a shape of a square or rectangle and a beveled end opposite the end with the cutout, wherein the beveled end bends inwards into the hollow elongated tube and is configured to secure an implantable physiological monitor within the hollow elongated tube prior to implantation but allow the hollow elongated tube to retract over the implantable physiological monitor during implantation,

wherein the implantable physiological monitor is inductively chargeable while preloaded in the hollow elongated tube;

a stationary arbor affixed to a proximal end of the cylindrical handle, wherein the stationary arbor is configured to extend past a distal end of the cylindrical handle, and wherein the stationary arbor is configured to extend past a distal end of the hollow elongated tube when the hollow elongated tube is in a fully retracted position;

a tab directly affixed to the hollow elongated tube via a cutout formed in a surface of the hollow elongated tube, wherein a bottom of the tab is secured into the cutout and a top of the tab extends outside the cylindrical handle, and the tab is configured to lock the hollow elongated tube in an extended position; and

a charging device to recharge a battery of the insertable physiological monitor.

13. The system according to claim 12 , further comprising:

an incision tool comprising a handle and a blade affixed to a distal end of the handle.

14. The system according to claim 12 , further comprising:

a tunneller tool comprising a handle and a rod affixed to a distal end of the handle.

15. The system according to claim 12 , wherein the hollow elongated tube is plastic.

16. The system according to claim 12 , further comprising:

a tip formed on a distal end of the hollow elongated tube.

Assignments (3)
RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021) Recorded Dec 14, 2021
From: JPMORGAN CHASE BANK, N.A.
To: BREATHE TECHNOLOGIES, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM, INC.; VOALTE, INC.; BARDY DIAGNOSTICS, INC.; HILL-ROM HOLDINGS, INC.
Reel/Frame 058516/0312 →
SECURITY AGREEMENT SUPPLEMENT Recorded Oct 25, 2021
From: BARDY DIAGNOSTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058567/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2021
From: BARDY, GUST H.; FLOYD, JARED; CHOI, JOHN; REDDY, DANIEL L.; CRAN, BRIAN
To: BARDY DIAGNOSTICS, INC.
Reel/Frame 057809/0643 →
Continuity (2)
Provisional Application 62938793 · Nov 21, 2019
Related Publication 20210153813A1 · May 27, 2021
References Cited (136)
US 3620216A · Szymanski · 1971 [cited by examiner]
US 4223674A · Fluent · 1980 [cited by examiner]
US 4846793A · Leonard · 1989 [cited by examiner]
US 5176649A · Wakabayashi · 1993 [cited by examiner]
US 5281197A · Arias · 1994 [cited by examiner]
US 5862803A · Besson et al. · 1999 [cited by applicant]
US 6190350B1 · Davis · 2001 [cited by examiner]
US 6248112B1 · Gambale · 2001 [cited by examiner]
US 7197357B2 · Istvan et al. · 2007 [cited by applicant]
US 7206630B1 · Tarler · 2007 [cited by applicant]
US 7212849B2 · Zhang et al. · 2007 [cited by applicant]
US 7395106B2 · Ryu et al. · 2008 [cited by applicant]
US 7468032B2 · Stahmann et al. · 2008 [cited by applicant]
US 7736330B2 · Bardy · 2010 [cited by applicant]
US 8150502B2 · Kumar et al. · 2012 [cited by applicant]
US 8214007B2 · Baker et al. · 2012 [cited by applicant]
US 8315695B2 · Sebelius et al. · 2012 [cited by applicant]
US 8483809B2 · Kim et al. · 2013 [cited by applicant]
US 8538503B2 · Kumar et al. · 2013 [cited by applicant]
US 8611980B2 · Choe et al. · 2013 [cited by applicant]
US 8647268B2 · Tran · 2014 [cited by applicant]
US 8718742B2 · Beck et al. · 2014 [cited by applicant]
US 8926509B2 · Magar et al. · 2015 [cited by applicant]
US 9211073B2 · Banet et al. · 2015 [cited by applicant]
US 9277864B2 · Yang et al. · 2016 [cited by applicant]
US 9510755B2 · Fong et al. · 2016 [cited by applicant]
US 9597143B2 · Madan · 2017 [cited by examiner]
US 9669212B2 · Mueller et al. · 2017 [cited by applicant]
US 10327660B2 · Gallego et al. · 2019 [cited by applicant]
US 10413251B2 · Golda et al. · 2019 [cited by applicant]
US 10441185B2 · Rogers et al. · 2019 [cited by applicant]
US 10548632B2 · Sick · 2020 [cited by examiner]
US 11051743B2 · Felix et al. · 2021 [cited by applicant]
US 11116447B2 · Yang et al. · 2021 [cited by applicant]
US 11445967B2 · Felix et al. · 2022 [cited by applicant]
US 20040111095A1 · Gordon · 2004 [cited by examiner]
US 20040199140A1 · Rue · 2004 [cited by examiner]
US 20070249992A1 · Bardy · 2007 [cited by examiner]
US 20080091089A1 · Guillory et al. · 2008 [cited by applicant]
US 20090062670A1 · Sterling et al. · 2009 [cited by applicant]
US 20090099469A1 · Flores · 2009 [cited by applicant]
US 20090177073A1 · Sonnenborg · 2009 [cited by applicant]
US 20090182204A1 · Semler et al. · 2009 [cited by applicant]
US 20100022863A1 · Mogensen · 2010 [cited by examiner]
US 20110009729A1 · Shin et al. · 2011 [cited by applicant]
US 20110041613A1 · Tran · 2011 [cited by examiner]
US 20110054285A1 · Searle et al. · 2011 [cited by applicant]
US 20110077497A1 · Oster et al. · 2011 [cited by applicant]
US 20110125040A1 · Crawford et al. · 2011 [cited by applicant]
US 20120323098A1 · Moein et al. · 2012 [cited by applicant]
US 20130225967A1 · Esposito · 2013 [cited by applicant]
US 20140276928A1 · Vanderpool et al. · 2014 [cited by applicant]
US 20140324067A1 · Emken et al. · 2014 [cited by applicant]
US 20150022372A1 · Vosch · 2015 [cited by applicant]
US 20150032062A1 · Jakob · 2015 [cited by examiner]
US 20150087950A1 · Felix et al. · 2015 [cited by applicant]
US 20160066850A1 · Brockway · 2016 [cited by examiner]
US 20160235346A1 · Liu et al. · 2016 [cited by applicant]
US 20180168686A1 · Jin et al. · 2018 [cited by applicant]
US 20180256108A1 · Au-Yeung · 2018 [cited by examiner]
US 20180280056A1 · Austin et al. · 2018 [cited by applicant]
US 20190223806A1 · Bennet et al. · 2019 [cited by applicant]
WO WO03065926A2 · 2003 [cited by applicant]
WO WO2008005015A1 · 2008 [cited by applicant]
WO 2010104952 · 2010 [cited by applicant]
WO WO2010104952A2 · 2010 [cited by applicant]
WO WO2012015955 · 2012 [cited by examiner]
May 2, 2022 Letter From Counsel. 1:22-cv-00351-CFC. May 2, 2022. [cited by applicant]
May 24, 2022 Letter to Opposing Counsel. 1:22-cv-00351-CFC. May 24, 2022. [cited by applicant]
Complaint from Case No. 1:22-cv-00351-UNA, [cited by applicant]
Defendant's Opening Brief In Support of Its Motion To Dismiss For Failure to State A Claim from Case No. 1:22-cv-00351-CFC, [cited by applicant]
Defendant's Answer, Defenses, and Counterclaim from Case No. 1:22-cv-00351-CFC, [cited by applicant]
Plaintiff's Answering Brief In Opposition to Defendant's Motion to Dismiss For Failure to State a Claim from Case No. 1:22-cv-00351-CFC, [cited by applicant]
Plaintiff's Answer to Defendant's Counterclaim from Case No. 1:22-cv-00351-CFC, [cited by applicant]
Defendant's Reply Brief In Support of Its Motion to Dismiss For Failure to State a Claim from Case No. 1:22-cv-00351- CFC, [cited by applicant]
Oct. 17, 2022 Letter to Opposing Counsel, [cited by applicant]
Nov. 11, 2022, Letter from Opposing Counsel, 1:22-cv-00351-CJB; [cited by applicant]
Dec. 26, 2022 Letter from Opposing Counsel, 1:22-cv-00351-CJB; [cited by applicant]
First Amended Complaint for Patent Infringement, 1:22-cv-00351-CJB, [cited by applicant]
Petition for Inter Partes Review of U.S. Pat. No. 11,051,743 Pursuant To 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42, Case No. IPR2023-00381, [cited by applicant]
Defendant's Answer to First Amended Complaint, Defenses, and Counterclaim, 1:22-cv-00351-CJB, [cited by applicant]
[Corrected] Chart CC-2 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Patent No. by U.S. Pat. Pub. No. 2011/0077497 (“Oster”) and U.S. Pat. No. 11,116,447 (“Yang”); … [cited by applicant]
[Corrected] Chart C-2 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. Pub. No. 2011/0077497 (“Oster”) and U.S. Pat. No. 11,116,447 (“… [cited by applicant]
Chart AA-1 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by International Publication No. WO 2010/104952 to Mazar (“Mazar”) and U.S. Pat. No. 11… [cited by applicant]
Chart C-1 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by International Publication No. WO 2010/104952 to Mazar (“Mazar”) and U.S. Pat. No. 11,… [cited by applicant]
Chart B-7 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); A Patch Comprising Adhered Layers; Oct. 25, 2023; 16 pages. [cited by applicant]
Chart B-6 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Hydrocolloid Adhesives on a Portion of the Backing; Oct. 25, 2023; 5 pages. [cited by applicant]
Chart B-5 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Conversion of Electrocardiogramals From One Format to Another; Oct. 25, 2023; 6 pages. [cited by applicant]
Chart B-4 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; The Case No. 22-351-CJB (Delaware); Rounded Outer Edge of Backing Ends; Oct. 25, 2023; 5 pages. [cited by applicant]
Chart B-3 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Flexible Circuit Comprising a Pair of Circuit Traces To Couple Electrodes; Oct. 25, 2023; 8 pages. [cited by applicant]
Chart B-2 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); An Electrocardiogramactrode On Each End Of The Backing; Oct. 25, 2023; 8 pages. [cited by applicant]
Chart B-1 Invalidity Contentions: U.S. Pat. No. 11,051,743 and U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Elongated Strip With Narrowed Midsection; Oct. 25, 2023; 8 pages. [cited by applicant]
Chart AA-10 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by WO 2003/065926 (“Ozguz”); Oct. 25, 2023; 6 pages. [cited by applicant]
Chart AA-9 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. Pub. No. 2011/0009729 (“Shin”); Oct. 25, 2023; 6 pages. [cited by applicant]
Chart AA-8 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by WO 2008/005015 (“Shennib”); Oct. 25, 2023; 6 pages. [cited by applicant]
Chart AA-7 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. No. 7,206,630 (“Tarler”); Oct. 25, 2023; 7 pages. [cited by applicant]
Chart AA-6 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. No. 9,669,212 (“Mueller”); Oct. 25, 2023; 6 pages. [cited by applicant]
Chart AA-5 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. No. 10,413,251 (“Golda”); Oct. 25, 2023; 6 pages. [cited by applicant]
Chart A-4 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. Pub. No. 2011/0077497 (“Oster”); Oct. 25, 2023; 6 pages. [cited by applicant]
Chart A-3 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. No. 10,327,660 (“Gallego”); Oct. 25, 2023; 7 pages. [cited by applicant]
Chart AA-2 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by U.S. Pat. No. 11,116,447 (“Yang”); Oct. 25, 2023; 14 pages. [cited by applicant]
Chart AA-1 Invalidity Contentions: U.S. Pat. No. 11,445,967; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,445,967 by International Publication No. WO 2010/104952 to Mazar (“Mazar”); Oct. 25, 2023; 13 p… [cited by applicant]
Chart A-10 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by WO 2003/065926 (“Ozguz”); Oct. 25, 2023; 12 pages. [cited by applicant]
Chart A-9 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. Pub. No. 2011/0009729 (“Shin”); Oct. 25, 2023; 12 pages. [cited by applicant]
Chart A-8 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by WO 2008/005015 (“Shennib”); Oct. 25, 2023; 12 pages. [cited by applicant]
Chart A-7 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. No. 7,206,630 (“Tarler”); Oct. 25, 2023; 12 pages. [cited by applicant]
Chart A-6 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. No. 9,669,212 (“Mueller”); Oct. 25, 2023; 11 pages. [cited by applicant]
Chart A-5 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. No. 10,413,251 (“Golda”); Oct. 25, 2023; 11 pages. [cited by applicant]
Chart A-4 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. Pub. No. 2011/0077497 (“Oster”); Oct. 25, 2023; 11 pages. [cited by applicant]
Chart A-3 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. No. 10,327,660 (“Gallego”); Oct. 25, 2023; 12 pages. [cited by applicant]
Chart A-2 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by U.S. Pat. No. 11,116,447 (“Yang”); Oct. 25, 2023; 19 pages. [cited by applicant]
Chart A-1 Invalidity Contentions: U.S. Pat. No. 11,051,743; Case No. 22-351-CJB (Delaware); Invalidity of U.S. Pat. No. 11,051,743 by International Publication No. WO 2010/104952 to Mazar (“Mazar”); Oct. 25, 2023; 19 pa… [cited by applicant]
[cited by applicant]
Wolf, “The Data-Driven Life,” New York Times Magazine, Apr. 28, 2010, 13 pages. [cited by applicant]
Hill, “Adventures in Self-Surveillance: Fitbit, Tracking My Movement and Sleep,” Forbes, Feb. 25, 2011, 11 pages. [cited by applicant]
Mehen, “Open health with the quantified self,” Opensource.com, Aug. 25, 2011, 7 pages. [cited by applicant]
“23 Personal Tools to Learn More About Yourself,” Flowingdata.com, Sep. 18, 2008, 18 pages. [cited by applicant]
Puurtinen et al., “Estimation of ECG Signal of closely separated bipolar electrodes using thorax models,” Proceedings of the 26th Annual International Conference of the IEEE EMBS pp. 801-804, San Francisco, Calif., USA,… [cited by applicant]
TrägÅrdh et al., How many ECG leads do we need? Cardiol Clin. Aug. 2006;24(3):317-30, vii. doi: 10.1016/j.ccl.2006.04.005. PMID: 16939826; 14 pages. [cited by applicant]
Adams et al., U.S. Appl. No. 61/755,623, filed Jan. 23, 2013, 48 pages. [cited by applicant]
Toth et al., U.S. Appl. No. 61/832,131, filed Jun. 6, 2013, 82 pages. [cited by applicant]
Vishnubhotla, “Pre-processing of ECG signals for ambulatory use,” Jan. 2009; 5 pages. [cited by applicant]
Chaimanonart et al., “A wireless batteryless in vivo EKG and body temperature sensing microsystem with adaptive RF powering for genetically engineered mice monitoring,” Jul. 2009; 4 pages. [cited by applicant]
Alzaidi et al., “Smart Textiles Based Wireless ECG System,” May 2012; 5 pages. [cited by applicant]
Saeed et al., “A Scalable Wireless Body Area Sensor Network for Health-Care Monitoring,” Jun. 2009, 4 pages. [cited by applicant]
Pandian et al., “Wireless Sensor Network for Wearable Physiological Monitoring,” Journal of Networks, vol. 3, No. 5, May 2008; 15 pages. [cited by applicant]
Mukala et al., “A Novel Zigbee-based Low-cost, Low-Power Wireless EKG system,” IEEE, May 2010; 4 pages. [cited by applicant]
Aventyn, Inc., “Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring”, Dec. 12, 2013, 5 pages. [cited by applicant]
Anand et al., “Design of the Multi-Sensor Monitoring in Congestive Heart Failure (MUSIC) Study: Prospective Trial to Assess the Utility of Continuous Wireless Physiologic Monitoring in Heart Failure”, Journal of Cardiac… [cited by applicant]
Cesario et al., “Arrhythmia Detection with a Low-Profile Wireless Adherent Cardiac Monitor: Results from the ADAM and EVE Studies”, The Journal of Innovations in Cardiac Rhythm Management, 2 (2011) Sep. 2011, pp. 476-48… [cited by applicant]
Corventis Nuvant, “Nuvant Mobile Cardiac Telementry (MTC) System”, Corventis, 2009, last printed Jul. 18, 2024, https://web.archive.org/web/20100127193736/http://corventis.com/AP/nuvant.asp. [cited by applicant]
Corventis Avivo, “Avivo Mobile Patient Management System”, Corventis, 2008, lasted printed Jul. 18, 2024, https://web.archive.org/web/20100118155329/http://www.corventis.com/AP/avivo.asp. [cited by applicant]
IRhythm ZIO XT Patch/Event Card, “Zio Patch”, iRhythm, 2011, last printed Jul. 18, 2024, https://web.archive.org/web/20111017074139/http://irhythmtech.com/media/files/Z100A4020.04%20-%20ZIO%20PATCH%20DATA%20SHEET.pdf. [cited by applicant]
[cited by applicant]
International Preliminary Report on Patentability and Written Opinion, PCT/US2019/064331, Jun. 8, 2021. [cited by applicant]
First Examination Report, Communication pursuant to Article 94(3) EPC, 19 828 053.9-1113, dated Apr. 15, 2024. [cited by applicant]